Methyldopa recalls
The FDA has published 1 recall involving Methyldopa since 2014. The latest was reported on 21 May 2014. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 21 May 2014
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why methyldopa is recalled
Companies
By year
All methyldopa recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Methyldopa Tablets USP, 500 mg recalled by Teva Pharmaceuticals U | Teva Pharmaceuticals USA | Manufacturing (CGMP) Deviations | Nationwide |
Should you stop taking Methyldopa?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.